Sirivella S, Gielchinsky I, Parsonnet V
Department of Cardiovascular and Thoracic Surgery, Newark Beth Israel Medical Center, New Jersey 07112, USA.
Ann Thorac Surg. 2000 Feb;69(2):501-6. doi: 10.1016/s0003-4975(99)01298-9.
Acute renal failure occurring in the postoperative period, requiring dialysis after cardiac surgery is an important risk factor for an early mortality, and the overall mortality of this complication is as high as 40% to 60%. Dialysis in the early postoperative period is often complicated by acute hemodynamic, metabolic, and hematologic effects that adversely affect cardiopulmonary function in patients stabilizing from recent surgery. The purpose of this study was to avoid the need for dialysis by infusion of the solution of mannitol, furosemide, and dopamine in the early postoperative period in oliguric renal failure.
One hundred patients with postoperative oliguric or anuric renal failure despite adequate postoperative cardiac output and hemodynamic function were randomized. Forty patients (group A) were given intermittent doses of diuretics (furosemide, bumetadine, and ethracrynic acid) and fluids. Sixty patients (group B) were given continuous infusion of the solution of mannitol, furosemide, and dopamine; the infusion was started within 6 hours (mean 3.5 hours) in subgroup B1 (n = 30), and later than 6 hours (mean 7.5 hours) in subgroup B2 (n = 30) after the onset of renal failure.
Diuresis occurred in 93.3% of group B (n = 56) versus 10% in group A (n = 4; patients with preop normal renal function). Ninety percent of group A (n = 36) required dialysis versus only 6.7% of group B (n = 4; patients with preexisting renal disease of subgroup B2). Renal function returned to preoperative normal (serum creatinine 0.9 +/- 0.05, p < 0.0001) or baseline value (serum creatinine 2.5 +/- 0.01, p < 0.0001) after first postoperative week in subgroup B1 and third postoperative week in subgroup B2.
Infusion of solution of mannitol, furosemide, and dopamine promoted diuresis in patients with acute postoperative renal failure with adequate postoperative cardiac output and had decreased the need for dialysis in the majority of patients. Early administration of this solution in acute renal failure caused early restoration of renal function to normal or baseline status. It remains to be determined whether routine administration of this solution in the early postoperative period for oliguric renal failure influences the long-term mortality and morbidity in those patients who do require dialysis.
术后发生的急性肾衰竭,心脏手术后需要透析是早期死亡的一个重要危险因素,这种并发症的总体死亡率高达40%至60%。术后早期透析常伴有急性血流动力学、代谢和血液学效应,对近期手术病情趋于稳定的患者心肺功能产生不利影响。本研究的目的是通过在术后早期少尿性肾衰竭时输注甘露醇、呋塞米和多巴胺溶液来避免透析的需要。
100例术后尽管心输出量和血流动力学功能正常但仍出现少尿或无尿性肾衰竭的患者被随机分组。40例患者(A组)给予间断剂量的利尿剂(呋塞米、布美他尼和依他尼酸)和补液。60例患者(B组)给予甘露醇、呋塞米和多巴胺溶液持续输注;B1亚组(n = 30)在肾衰竭发生后6小时内(平均3.5小时)开始输注,B2亚组(n = 30)在肾衰竭发生后6小时后(平均7.5小时)开始输注。
B组93.3%(n = 56)出现利尿,而A组仅10%(n = 4;术前肾功能正常的患者)出现利尿。A组90%(n = 36)需要透析,而B组仅6.7%(n = 4;B2亚组中原有肾脏疾病的患者)需要透析。B1亚组术后第一周和B2亚组术后第三周肾功能恢复到术前正常水平(血清肌酐0.9 +/- 0.05,p < 0.0001)或基线值(血清肌酐2.5 +/- 0.01,p < 0.0001)。
输注甘露醇、呋塞米和多巴胺溶液可促进术后急性肾衰竭且术后心输出量充足的患者利尿,并减少了大多数患者的透析需求。在急性肾衰竭时早期给予该溶液可使肾功能早期恢复至正常或基线状态。对于少尿性肾衰竭患者,在术后早期常规给予该溶液是否会影响那些确实需要透析的患者的长期死亡率和发病率,仍有待确定。